Tenax Therapeutics, Inc. · NASDAQ:TENX
Staab Thomas R II bought 5,675 Tenax Therapeutics, Inc. shares (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Staab Thomas R II (Chief Financial Officer) bought 5,675 Tenax Therapeutics, Inc. shares at US$1.94 for US$11,010, leaving 15,675 shares. Filed Sep 15, 2026 (Form 4).
- Bought
- 5,675 shares
- Price
- US$1.94
- Value
- US$11,010
- Holding after
- 15,675 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Buy | 5,675 | US$1.94 | 15,675 | Direct |
Source
Related
- Tenax Therapeutics, Inc.
- Staab Thomas R II
- Tenax Therapeutics, Inc. shareholders
- Form 4 · Staab Thomas R II · May 13, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026